ALHC — Alignment Healthcare, Inc.

Summary of Alignment Healthcare's Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Membership Growth: Health plan membership reached 236,300, a 25% increase year-over-year.
• Revenue: Total revenue for Q4 was $1 billion, up 44% year-over-year; full-year revenue totaled $3.9 billion, a 46% increase.
• Profitability: Adjusted gross profit for Q4 was $125 million with an adjusted medical benefit ratio (MBR) of 87.7%. Full-year adjusted gross profit was $495 million, improving MBR to 87.5%.
• Adjusted EBITDA: Q4 adjusted EBITDA was $11 million, exceeding guidance; full-year adjusted EBITDA reached $110 million, reflecting a margin of 2.8% and a 270 basis point improvement year-over-year.
• Cash Position: Ended 2025 with $604 million in cash and investments and closed a $200 million revolving credit facility.

2. Strategic Updates and Business Highlights

• Operational Model: Continued emphasis on a clinically centric model, leveraging the AIVA technology platform and Care Anywhere clinical model to enhance care quality and cost management.
• Market Expansion: More than doubled membership outside California, now accounting for 16% of total membership. Achieved multiple 5-star ratings in various states, indicating strong quality performance.
• Growth Strategy: Plans to invest in sales and distribution, deepen broker relationships, and enhance operational efficiencies to sustain growth momentum, particularly in ex-California markets.

3. Forward Guidance and Outlook

• 2026 Membership and Revenue: Expected membership growth to 292,000-298,000 members, with revenue projected between $5.14 billion and $5.19 billion.
• Profitability Guidance: Anticipated adjusted gross profit of $615 million to $650 million, with adjusted EBITDA forecasted between $133 million and $163 million.
• Seasonality: Anticipated lower MBR in the first half of 2026, with a slight increase expected in the second half.

4. Challenges and Points of Concern

• Regulatory Environment: Concerns regarding the flat rate environment for 2027, with potential impacts from CMS policy changes and adjustments to risk models.
• Member Mix: New members, particularly those categorized as dual-eligible and C-SNP, typically exhibit higher MBRs initially, which could pressure profitability in the short term.
• Competitive Pressures: Industry peers are facing challenges with rate adjustments, which could lead to increased competition for membership and benefits.

5. Notable Q&A Insights

• Growth Sustainability: Management expressed confidence in maintaining a 20% growth rate, emphasizing disciplined growth strategies and operational improvements.
• MLR Assumptions: Questions about the modest MBR improvement in guidance were addressed, highlighting the impact of new member mix and ongoing risk model transitions.
• Broker Relationships: The company is focused on strengthening broker partnerships, particularly in new markets, to enhance distribution and member engagement.
• Regulatory Comments: Management remains optimistic about the MA program's future, believing that a focus on quality and cost management will position them favorably, regardless of regulatory changes.

Overall, Alignment Healthcare demonstrated strong financial performance in 2025, with significant growth and profitability improvements, while navigating a challenging regulatory landscape and preparing for future expansion.